John Ashcroft
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Hematology 28
- Multiple Myeloma Research and Treatments 26
- Oncology 31
- Bone health and treatments 12
- Cancer Treatment and Pharmacology 9
- Cancer Diagnosis and Treatment 5
- Peptidase Inhibition and Analysis 5
- COVID-19 and healthcare impacts 5
- Co-authors
- Geoffrey Meads (2 shared papers)Guy Pratt (11 shared papers)Sylvia Feyler (6 shared papers)John Andrew Snowden (9 shared papers)Jennifer M. Bird (5 shared papers)Eric Low (3 shared papers)Shirley D’Sa (2 shared papers)Gordon C Cook (16 shared papers)
- Journals
- Blood (11 papers)British Journal of Haematology (11 papers)The Lancet (6 papers)British journal of surgery (4 papers)Value in Health (2 papers)
- Partner nations
- United KingdomSwitzerlandSpain
In The Last Decade
John Ashcroft
60 papers receiving 3.1k citations
John Ashcroft's Hit Papers
Peers
Comparison fields: 5 of 136
- Hematology 767
- Infectious Diseases 993
- Oncology 844
- Applied Microbiology and Biotechnology 50
- Neurology 364
Countries citing papers authored by John Ashcroft
This map shows the geographic impact of John Ashcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ashcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ashcroft more than expected).
Fields of papers citing papers by John Ashcroft
This network shows the impact of papers produced by John Ashcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ashcroft. The network helps show where John Ashcroft may publish in the future.
Co-authors
The 25 scholars most cited alongside John Ashcroft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | 2011 | 247 | |
| 5 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 6 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 7 | 2009 | 188 | |
| 8 | 2011 | 169 | |
| 9 | 2020 | 167 | |
| 10 | 2005 | 89 | |
| 11 | 2023 | 83 | |
| 12 | 2018 | 68 | |
| 13 | 2000 | 66 | |
| 14 | The case for interprofessional collaboration : in health and social care | 2005 | 62 |
| 15 | 2020 | 54 | |
| 16 | 2008 | 48 | |
| 17 | 2013 | 48 | |
| 18 | 2014 | 42 | |
| 19 | 2021 | 35 | |
| 20 | 2014 | 29 |
About John Ashcroft
John Ashcroft is a scholar working on Hematology, Oncology, Genetics, Infectious Diseases and Emergency Medicine, having authored 64 papers that have together received 3.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Bone health and treatments (12 papers), Protein Degradation and Inhibitors (10 papers), Cancer Treatment and Pharmacology (9 papers), Management of metastatic bone disease (6 papers), Cancer Diagnosis and Treatment (5 papers), Peptidase Inhibition and Analysis (5 papers) and COVID-19 and healthcare impacts (5 papers). The work is most often cited by research in Hematology (767 citations), Infectious Diseases (993 citations), Oncology (844 citations), Applied Microbiology and Biotechnology (50 citations) and Neurology (364 citations). John Ashcroft has collaborated with scholars based in United Kingdom, Switzerland and Spain. Frequent co-authors include Geoffrey Meads, Guy Pratt, Sylvia Feyler, John Andrew Snowden, Jennifer M. Bird, Eric Low, Shirley D’Sa, Gordon C Cook, Roger G. Owen and Gareth John Morgan. Their work appears in journals such as Blood, British Journal of Haematology, The Lancet, British journal of surgery and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.